APLIF   $0.0327  16.21% Market Closed

Appili Therapeutics Inc
Total Cash 301.26K
totalCashPerShare 0.002
EBITDA -8.59M
Total Debt 10.05M
quickRatio 0.152
currentRatio 0.16
Total Revenue 827.41K
debtToEquity
Revenue/Share 0.007
ROA -2.44223
ROE
grossProfits
freeCashflow -5.77M
operatingCashflow -572.66K
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -10.39876
profitMargins 0.0
enterpriseValue 12.63M
forwardPE
floatShares 106.83M
sharesOutstanding 121.27M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.00%
heldPercentInstitutions 0.12%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.102
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -3.82M
trailingEps -0.02%
forwardEps -0.05%
enterpriseToEbitda -1.47
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 1
lastUpdated Oct. 16, 2024, 9:47 p.m.